Olibix financials
A multi-period view of the public annual-account figures reported for Olibix, with comparable measures and links to available source documents.
Company overviewRegistry number
1014259120
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for Olibix
2025 versus 2024
- Operating line
- €77,343
- EBITDA
- €76,557
- Total assets
- €90,743
- Equity
- €79,890
+107.1%
+104.9%
+5.8%
+158.7%
EBITDA margin +99% · Equity ratio +88%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €77,343 | €76,557 | €90,743 | €79,890 | - |
| 202431 Dec 2024 | €37,355 | €37,355 | €85,782 | €30,877 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.